Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C010914 |
2,4-diaminotoluene |
2,4-diaminotoluene results in increased expression of FXYD5 mRNA | increases expression | 20713471
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of FXYD5 mRNA | affects expression | 17562736
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of FXYD5 protein | affects expression | 20106945
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of FXYD5 mRNA | decreases expression | 20127859
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of FXYD5 mRNA | increases expression | 15336504
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of FXYD5 mRNA | increases expression | 15003993 14729362
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of FXYD5 mRNA | increases expression | 20106945
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FXYD5 mRNA | affects cotreatment|increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of FXYD5 mRNA | increases expression | 17557909
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of FXYD5 mRNA | affects cotreatment|increases expression | 17183730
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in increased expression of FXYD5 mRNA | increases expression | 14729362
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in increased expression of FXYD5 mRNA | increases expression | 20713471
|
D010126 |
Ozone |
Ozone results in increased expression of FXYD5 mRNA | increases expression | 16716893
|
D010656 |
Phenylephrine |
Phenylephrine results in increased expression of FXYD5 mRNA | increases expression | 18158353
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of FXYD5 mRNA | increases expression | 18175754
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FXYD5 mRNA | affects cotreatment|increases expression | 17942748
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of FXYD5 mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.48 | 15322242 14514962 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
8.48 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.96 | 19490988 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.00 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.20 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.20 | 14692618 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
6.92 | 6695378 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
6.92 | 6695378 10545420 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.43 | 16835633 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
2.44 | 15513908 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.30 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.97 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.91 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.59 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.12 | 19183758 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
4.14 | 17460149 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.51 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.68 | 15885639 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.56 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.64 | 17854713 16373670 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
3.47 | 11922910 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.85 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.85 | 20603192 18775368 18985861 18396377 18558336 18177632 15238991 19460635 18316065 16609825 17507914 17688650 17157402 19232924 18940202 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.09 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.07 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.85 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.08 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.08 | 8888407 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.59 | 15306635 |
MESH:D001943 |
Breast Neoplasms |
|
2,4-diaminotoluene |
2.00 | 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.00 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
2.00 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.00 | 20435547 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.70 | 18417511 16777450 15516495 17626835 18315731 14754758 19059883 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.79 | 16183385 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
8.41 | 10545420 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.41 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
2.90 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
2.90 | 21507988 12619106 12907637 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.06 | 20419170 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
6.93 | 17124262 17287366 15728586 11179087 16170337 11754973 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.93 | 16120746 18670907 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
3.53 | 16936243 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.60 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.91 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
6.91 | 16192471 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.72 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.19 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.84 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.84 | 16105132 11677210 17681005 17333356 17110522 15861022 16919318 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.79 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.11 | 12621046 15340226 15668235 8697196 16354765 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.08 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.48 | 10048152 15322242 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.48 | 17688650 16575769 8888407 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.80 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
9.03 | 12705907 19370779 16081117 12153990 17522070 17562736 11421492 12392966 19085960 19739265 14725611 19420014 11834606 12540782 16781746 19164858 16227642 11739529 17906064 16393943 11461765 18713872 18071297 19923254 19416960 11743745 14986274 10915739 16177239 11529661 16109766 2444490 12958197 10663392 10774834 14550746 15968718 15619225 16485898 12594235 11287661 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
9.03 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
9.03 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
9.03 | 1733752 19641884 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.16 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.78 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.08 | 1851702 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.41 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.96 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.22 | 12538720 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.05 | 10568697 9294722 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.19 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.98 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.95 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.61 | 6254150 7562514 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.34 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.11 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.01 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.03 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
13.25 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
13.25 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
13.25 | 19224547 14986274 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.50 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.95 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.17 | 18558336 8888407 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
4.99 | 14633661 10962813 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.62 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.62 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.74 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.27 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.66 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.49 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.49 | 11294989 10048152 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.47 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.36 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.93 | 15340226 16120746 12621046 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.92 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.11 | 8697196 16354765 15340226 18606429 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.72 | 16870215 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.67 | 10903974 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
8.67 | 12717712 8949925 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.67 | 18670907 18850075 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.67 | 16612254 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.58 | 12791704 18502941 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.85 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.49 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.50 | 17937319 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.87 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.29 | 14714311 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.36 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.50 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.85 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.85 | 8314463 10903974 18776723 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
4.30 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.76 | 12371664 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.15 | 16294345 17596541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.63 | 19460945 16611625 19784758 16610002 12969438 11587558 19014921 12587719 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.26 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
7.44 | 2125692 18177683 9163691 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.44 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.44 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
10.00 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
10.00 | 598648 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.00 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
3.39 | 19066396 8266340 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.32 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.89 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
6.63 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
6.63 | 20464547 20064080 18569708 17053015 18816296 20869020 20135361 6695378 18520028 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
6.63 | 7750092 11893704 1399818 15390079 16271038 10545420 9230183 6695378 16337739 20512841 20970405 21163286 17909032 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
6.63 | 7614698 8597069 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.63 | 19555203 11884234 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.09 | 14737004 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
2,4-diaminotoluene |
3.59 | 11921183 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.61 | 19513568 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.85 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
5.17 | 10496685 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.21 | 18765137 18803445 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.21 | 16381670 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.06 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.17 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.04 | 12213967 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.18 | 11141357 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.50 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.31 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.25 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.14 | 16359493 8888407 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.89 | 18514411 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.41 | 16870215 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.72 | 11578682 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
4.13 | 12065085 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.31 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Ozone |
4.17 | 16369182 |
MESH:D011014 |
Pneumonia |
|
Ozone |
4.44 | 18007984 18929643 18381685 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.59 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.25 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.63 | 11896295 11118676 11222880 11399792 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
9.63 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.22 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.22 | 18760546 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.36 | 15861022 16919318 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.60 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.24 | 16882103 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.87 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.21 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.07 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.75 | 11738929 16876388 1511512 17978042 3137016 15475178 14763951 11044598 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.75 | 7327846 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
13.68 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
13.68 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
13.68 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
13.68 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.00 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.80 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.60 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 2093021 20155912 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.65 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.18 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.96 | 12697716 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.30 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.57 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.19 | 17053015 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.68 | 8888407 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.01 | 10982225 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.33 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.05 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.66 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.57 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.31 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.50 | 17120751 |